Whittier Trust Co. raised its position in CVS Health Corporation (NYSE:CVS) by 1.9% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 155,102 shares of the pharmacy operator’s stock after buying an additional 2,893 shares during the period. Whittier Trust Co.’s holdings in CVS Health Corporation were worth $14,849,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Retirement Systems of Alabama boosted its stake in shares of CVS Health Corporation by 8.7% in the second quarter. Retirement Systems of Alabama now owns 1,043,349 shares of the pharmacy operator’s stock worth $99,890,000 after buying an additional 83,608 shares during the period. Atwood & Palmer Inc. boosted its stake in shares of CVS Health Corporation by 1.5% in the second quarter. Atwood & Palmer Inc. now owns 202,127 shares of the pharmacy operator’s stock worth $19,352,000 after buying an additional 3,059 shares during the period. TIAA CREF Trust Co. FSB MO boosted its stake in shares of CVS Health Corporation by 2.5% in the second quarter. TIAA CREF Trust Co. FSB MO now owns 200,005 shares of the pharmacy operator’s stock worth $19,149,000 after buying an additional 4,913 shares during the period. Sentry Investments Corp. boosted its stake in shares of CVS Health Corporation by 6.3% in the first quarter. Sentry Investments Corp. now owns 2,179,600 shares of the pharmacy operator’s stock worth $226,090,000 after buying an additional 128,300 shares during the period. Finally, Lodestar Investment Counsel LLC IL boosted its stake in shares of CVS Health Corporation by 4.2% in the second quarter. Lodestar Investment Counsel LLC IL now owns 176,387 shares of the pharmacy operator’s stock worth $16,887,000 after buying an additional 7,136 shares during the period. 80.89% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Shares of CVS Health Corporation (NYSE:CVS) traded down 2.41% during trading on Monday, reaching $86.66. 7,381,666 shares of the company traded hands. The stock has a market cap of $92.40 billion, a P/E ratio of 19.94 and a beta of 0.83. CVS Health Corporation has a 12 month low of $85.41 and a 12 month high of $106.67. The stock’s 50 day moving average price is $89.92 and its 200-day moving average price is $96.23.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.02. The company earned $43.70 billion during the quarter, compared to analyst estimates of $44.28 billion. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The company’s revenue for the quarter was up 17.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.19 EPS. On average, equities research analysts expect that CVS Health Corporation will post $5.86 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 3rd. Investors of record on Monday, October 24th will be given a $0.425 dividend. The ex-dividend date is Thursday, October 20th. This represents a $1.70 annualized dividend and a dividend yield of 1.96%. CVS Health Corporation’s dividend payout ratio is presently 39.08%.

A number of analysts have weighed in on CVS shares. Mizuho reissued a “buy” rating and set a $111.00 target price on shares of CVS Health Corporation in a report on Friday, September 30th. Morgan Stanley reaffirmed a “hold” rating and issued a $104.00 price objective on shares of CVS Health Corporation in a report on Monday, September 12th. Leerink Swann reaffirmed an “outperform” rating and issued a $105.00 price objective (down previously from $110.00) on shares of CVS Health Corporation in a report on Sunday, October 2nd. Vetr cut shares of CVS Health Corporation from a “strong-buy” rating to a “hold” rating and set a $87.73 price objective on the stock. in a report on Thursday, October 6th. Finally, Credit Suisse Group AG reaffirmed a “buy” rating and issued a $115.00 price objective on shares of CVS Health Corporation in a report on Tuesday, September 20th. Five equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $112.40.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.